Patent · US Active

Compounds as cannabinoid receptor ligands

US7875640B2 · kind B2 · utility

15Cited by

0References

28Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Teodozyj Kolasa · Lake Villa, US
Jennifer M. Frost · Grayslake, US
Meena Patel · Libertyville, US
Steven P. Latshaw · Round Lake, US
Arturo Perez-Medrano · Grayslake, US
Xueqing Wang · Evanston, US
Sridhar Peddi · Grayslake, US
William A. Carroll · Evanston, US
Michael J. Dart · Highland Park, US

Key dates

Filing date	Mar 19, 2008
Grant date	Jan 25, 2011
Priority date	—
Expiry date	Jul 22, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to thiazolylidene containing compounds of formula (I)wherein R1, R2, R3, R4, L2 and A are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.